Page last updated: 2024-11-02

pioglitazone and Angioedema

pioglitazone has been researched along with Angioedema in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Angioedema: Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shadid, S1
Jensen, MD1

Other Studies

1 other study available for pioglitazone and Angioedema

ArticleYear
Angioneurotic edema as a side effect of pioglitazone.
    Diabetes care, 2002, Volume: 25, Issue:2

    Topics: Angioedema; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Pioglitazone; Thiazoles;

2002